News and Articles of Interest

 
 

2023 Articles:

  1. Marcelo Monte Mor Rangel, Laís Calazans Menescal Linhares, Krishna Duro Oliveira et al. Evaluation of the safety and feasibility of electrochemotherapy with intravenous bleomycin as local treatment of bladder cancer in dogs, 24 March 2023, PREPRINT (Version 1) available at Research Square [https://doi.org/10.21203/rs.3.rs-2658010/v1]

2022 Articles:

  1. Rasteiro AM, Sá E Lemos E, Oliveira PA, Gil da Costa RM. Molecular Markers in Urinary Bladder Cancer: Applications for Diagnosis, Prognosis and Therapy. Vet Sci. 2022 Feb 28;9(3):107. doi: 10.3390/vetsci9030107. PMID: 35324835; PMCID: PMC8950778.

  2. Fukushima, H.; Turkbey, B.; Pinto, P.A.; Furusawa, A.; Choyke, P.L.; Kobayashi, H. Near-Infrared Photoimmunotherapy (NIR-PIT) in Urologic Cancers. Cancers 2022, 14, 2996. https://doi.org/10.3390/cancers14122996

2021 Articles:

  1. Mestrinho LA, Santos RR. Translational oncotargets for immunotherapy: from pet dogs to humans. Adv Drug Deliv Rev. 2021 Mar 8:S0169-409X(21)00067-3. doi: 10.1016/j.addr.2021.02.020. Epub ahead of print. PMID: 33705879.

  2. Smith, N, Luethcke, KR, Craun, K, Trepanier, L. Risk of bladder cancer and lymphoma in dogs is associated with pollution indices by county of residence. Vet Comp Oncol. 2022; 20( 1): 246- 255. doi:10.1111/vco.12771

2020 Articles:

  1. Malfassi L, Fidanzio F, Sala M, Marcarini S, Mazza G, Carrara N, Pavesi S, Gnudi G, Urso G, Dolera M. A combined protocol with piroxicam, chemotherapy and whole pelvic irradiation with simultaneous boost volumetric modulated arc radiotherapy for muscle-invasive canine urinary transitional cell carcinoma: first clinical experiences. J Vet Med Sci. 2020 Sep 22. doi: 10.1292/jvms.19-0662. Epub ahead of print. PMID: 32963177.

    Note: This study was conducted out of Italy, but it has some very impressive results in terms of survival times with minimal side effects.

  2. Knapp DW, Dhawan D, Ramos-Vara JA, et al. Naturally-Occurring Invasive Urothelial Carcinoma in Dogs, a Unique Model to Drive Advances in Managing Muscle Invasive Bladder Cancer in Humans. Front Oncol. 2020;9:1493. Published 2020 Jan 21. doi:10.3389/fonc.2019.01493

  3. Jack S, Madhivanan K, Ramadesikan S, Subramanian S, Edwards DF 2nd, Elzey BD, Dhawan D, McCluskey A, Kischuk EM, Loftis AR, Truex N, Santos M, Lu M, Rabideau A, Pentelute B, Collier J, Kaimakliotis H, Koch M, Ratliff TL, Knapp DW, Aguilar RC. A novel, safe, fast and efficient treatment for Her2-positive and negative bladder cancer utilizing an EGF-anthrax toxin chimera. Int J Cancer. 2020 Jan 15;146(2):449-460. doi: 10.1002/ijc.32719. Epub 2019 Nov 1. PMID: 31584195.

  4. Chae HK, Yang JI, An JH, et al. Use of oral paclitaxel for the treatment of bladder tumors in dogs. J Vet Med Sci. 2020;82(5):527-530. doi:10.1292/jvms.19-0578

  5. Iizuka K, Shoji K, Fujiyuki T, Moritoh K, Tamura K, Yoshida A, Sato H, Yoneda M, Asano K, Kai C. Antitumor activity of an oncolytic measles virus against canine urinary bladder transitional cell carcinoma cells. Res Vet Sci. 2020 Dec;133:313-317. doi: 10.1016/j.rvsc.2020.10.016. Epub 2020 Oct 22. PMID: 33183781.

  6. Parker HG, Dhawan D, Harris AC, Ramos-Vara JA, Davis BW, Knapp DW, Ostrander EA. RNAseq expression patterns of canine invasive urothelial carcinoma reveal two distinct tumor clusters and shared regions of dysregulation with human bladder tumors. BMC Cancer. 2020 Mar 24;20(1):251. doi: 10.1186/s12885-020-06737-0. PMID: 32209086; PMCID: PMC7092566.


2019 Articles:

  1. Elbadawy M, Usui T, Mori T, Tsunedomi R, Hazama S, Nabeta R, Uchide T, Fukushima R, Yoshida T, Shibutani M, Tanaka T, Masuda S, Okada R, Ichikawa R, Omatsu T, Mizutani T, Katayama Y, Noguchi S, Iwai S, Nakagawa T, Shinohara Y, Kaneda M, Yamawaki H, Sasaki K. Establishment of a novel experimental model for muscle-invasive bladder cancer using a dog bladder cancer organoid culture. Cancer Sci. 2019 Sep;110(9):2806-2821. doi: 10.1111/cas.14118. Epub 2019 Jul 23. PMID: 31254429; PMCID: PMC6726682.

  2. Maeda S, Murakami K, Inoue A, Yonezawa T, Matsuki N. CCR4 Blockade Depletes Regulatory T Cells and Prolongs Survival in a Canine Model of Bladder Cancer. Cancer Immunol Res. 2019 Jul;7(7):1175-1187. doi: 10.1158/2326-6066.CIR-18-0751. Epub 2019 Jun 3. PMID: 31160277.

  3. Cronise KE, Hernandez BG, Gustafson DL, Duval DL. Identifying the ErbB/MAPK Signaling Cascade as a Therapeutic Target in Canine Bladder Cancer. Mol Pharmacol. 2019 Jul;96(1):36-46. doi: 10.1124/mol.119.115808. Epub 2019 May 2. Erratum in: Mol Pharmacol. 2020 Jul;98(1):23. PMID: 31048548.

Earlier Articles:

  1. Filion, Mario & Lucas, Rodrigues & Chad, Johannes & Masic, Aleksandar. (2017). The in Vitro and in Vivo Anti-Cancer Potential of Mycobacterium Cell Wall Fraction (MCWF) Against Canine Transitional Cell Carcinoma of the Urinary Bladder. Acta Veterinaria. 67. 10.1515/acve-2017-0039. Immunocidin